New Nordic EMBL Partnership for Molecular Medicine will advance the understanding of molecular mechanisms underpinning disease
The partnership between EMBL, the Institute for Molecular Medicine Finland, the Centre for Molecular Medicine Norway and the Laboratory for Molecular Infection Medicine Sweden is dedicated to molecular medicine, a growing field in the life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments.
“Each partner has a long history of research in specific areas relevant to molecular medicine and brings in a unique set of expertise, skills and facilities,” says Iain Mattaj, Chair of the partnership's steering committee and Director General at EMBL. “Combining complementary strengths in the new Nordic EMBL Partnership equips us to tackle some of the most challenging problems of biomedicine.”
EMBL's recognised research strengths in the areas of molecular, cellular and developmental biology, bioinformatics and structural biology will be complemented by Norway's expertise in molecular mechanisms of disease, Sweden's focus on microbial pathogenicity and molecular infection medicine and Finland's strength in genetic epidemiology.
The agreement will facilitate access to scientific infrastructure, including databases, facilities and instrumentation, as well as to services and training activities provided by the partners. The partnership will result in the adoption of the EMBL model for international recruitment, staff turnover and scientific reviews by the Nordic nodes. The coordination between the Nordic nodes and EMBL will be overseen by a steering committee constituted by two representatives from each node. Scientific progress will be reviewed regularly by a committee of external experts. In addition to their partnership with EMBL the individual Nordic research centres will engage in collaborations with other national partners, including research and public health institutes, hospitals and research councils, to establish an extensive Nordic network for molecular medicine.
Anna-Lynn Wegener
Press Officer
EMBL
Meyerhofstrasse 1
D-69117 Heidelberg
tel. +49-6221-3878452
fax +49-6221-387525
wegener@embl.de
Media Contact
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
